Stago (France)

HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease

Barry W. Festoff, Ravi K. Sajja, Patrick Van Dreden et al. · Journal of Neuroinflammation · 2016 · 202 citations · Full text

Stability of coagulation proteins in frozen plasma

Barry Woodhams, O. Girardot, Maria-Jose Blanco et al. · Blood Coagulation & Fibrinolysis · 2001 · 184 citations

Immunology, Protein Refolding, Thrombosis +19

Blunted ventral striatal responses to anticipated rewards foreshadow problematic drug use in novelty-seeking adolescents

Christian Büchel, Jan Peters, Tobias Banaschewski et al. · Nature Communications · 2017 · 117 citations · Full text

Thrombin-Activatable Fibrinolysis Inhibitor Antigen Levels and Cardiovascular Risk Factors

I. Juhan-Vague, Jean‐François Renucci, M. Grimaux et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2000 · 91 citations · Full text

Whole blood clots are more resistant to lysis than plasma clots - greater efficacy of rivaroxaban

R. Varin, Shahsultan Mirshahi, Pezhman Mirshahi et al. · Thrombosis Research · 2013 · 90 citations

Thrombosis, Greater Efficacy, Whole Blood Clots +8